Tubacin Histone Deacetylase 6 Inhibitor Produced α-Tubulin Acetylation, Cell Cycle Arrest, Aging, and Suppression of Migration of Mouse Fibroblasts Transformed by E1A and cHa-ras Oncogenes

Kukushkin, A. N.

DOI: https://doi.org/10.1134/S1990519X23020098

2023-04-28

Cell and Tissue Biology

Abstract:Inhibitors of histone - deacetylase activity are widely used to block cancer cell proliferation in clinical trials in vivo and in experiments involving tumor cells in vitro . In addition to suppressing tumor - cell proliferation, these inhibitors can induce either cell senescence or apoptotic cell death and autophagy. Histone deacetylase 6 (HDAC6, class II) differs from other HDACs (class I) in its predominantly cytoplasmic localization and low histone deacetylase activity. Moreover, HDAC6 deacetylates a number of non-histone proteins, including α-tubulin, a microtubule component, thereby affecting their stability. Overexpression of HDAC6 has been found in various tumor - cell lines and induced tumors in mice. Available evidence suggests that HDAC6 is involved in the control of the autophagy process, as α-tubulin acetylation is required for autophagosome fusion with lysosomes. In the present work, we compared effects of the HDAC inhibitor sodium butyrate and tubacin, a specific inhibitor of HDAC6, on E1A+Ras-transformed mouse fibroblasts (mERas line). Sodium butyrate inhibits the activity of HDAC I (but not HDAC6). It turned out that tubacin causes the same effects as sodium butyrate in terms of inhibition of cell growth, induction of a cell-cycle block at the G1/S phase boundary, and cellular senescence. Since tubacin induces α-tubulin acetylation, it can be assumed that a certain level of α-tubulin acetylation is required for the proliferation, senescence, and migration of mERas cells.